GleamWall
中文EN

GPLB Green Planet Bio Engineering Co. Ltd.

Biological Products, (No Diagnostic Substances) · OTC · SEC CIK 1392449 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-28.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets—
Debt / equity—
Current ratio0.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.32x
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue————————
SG&A expense$8,440$5,905$10,794$16,298$8,599$4,105$6,840$12,791
Interest expense——$150—————
Pretax income-$8,440-$5,905-$10,944-$16,298-$8,599-$4,105-$6,840-$12,791
Income tax$0$0$0$0$0$0$0$0
Net income-$8,440-$5,905-$10,944-$16,298-$8,599-$4,105-$6,840-$12,791
EPS (diluted)0.000.00——0.000.000.00—
Weighted avg. shares (diluted)20.01M20.01M20.01M—20.01M20.01M20.01M—
Balance sheet
Cash & equivalents$0$0$0$0$0$0$0$0
Current assets$0$0$0$0$0$0$0$0
Total assets————————
Current liabilities$526,265$517,825$511,920$500,976$484,678$476,079$471,974$465,134
Total liabilities$526,265$517,825$511,920$500,976$484,678$476,079$471,974$465,134
Shareholders' equity-$526,265-$517,825-$511,920-$500,976-$484,678-$476,079-$471,974-$465,134
Shares outstanding20.01M20.01M20.01M20.01M20.01M20.01M20.01M20.01M
Cash flow statement
Operating cash flow-$8,440-$12,654-$16,643-$17,030-$6,569-$6,030-$6,915-$11,291
Investing cash flow—$0$0—$0$0$0$35,044
Financing cash flow$8,440$12,654$16,643$17,030$6,569$6,030$6,915$11,291

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.